Concepts (119)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Biliary Atresia | 1 | 2023 | 204 | 0.660 |
Why?
|
| Education, Distance | 1 | 2020 | 68 | 0.650 |
Why?
|
| Cardiomyopathies | 1 | 2023 | 514 | 0.580 |
Why?
|
| Echocardiography | 2 | 2020 | 1124 | 0.560 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2009 | 444 | 0.490 |
Why?
|
| Ventricular Pressure | 1 | 2015 | 41 | 0.490 |
Why?
|
| Cardiology | 1 | 2020 | 520 | 0.470 |
Why?
|
| Echocardiography, Doppler | 1 | 2015 | 173 | 0.460 |
Why?
|
| Ventricular Function, Left | 2 | 2023 | 544 | 0.420 |
Why?
|
| Clinical Competence | 1 | 2020 | 1066 | 0.410 |
Why?
|
| Recovery of Function | 1 | 2015 | 474 | 0.410 |
Why?
|
| Child Mortality | 1 | 2012 | 26 | 0.390 |
Why?
|
| Cardiac Catheterization | 2 | 2018 | 662 | 0.380 |
Why?
|
| Heart Ventricles | 2 | 2018 | 799 | 0.370 |
Why?
|
| Aortic Valve Stenosis | 1 | 2015 | 346 | 0.360 |
Why?
|
| Magnetic Resonance Imaging, Cine | 2 | 2023 | 164 | 0.320 |
Why?
|
| Melanoma, Experimental | 1 | 2009 | 38 | 0.320 |
Why?
|
| Immunization, Secondary | 2 | 2009 | 111 | 0.310 |
Why?
|
| Vaccinia virus | 1 | 2009 | 53 | 0.310 |
Why?
|
| Smallpox Vaccine | 1 | 2009 | 38 | 0.310 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2009 | 141 | 0.290 |
Why?
|
| Arterial Switch Operation | 2 | 2018 | 24 | 0.290 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2009 | 215 | 0.290 |
Why?
|
| Cancer Vaccines | 1 | 2009 | 190 | 0.280 |
Why?
|
| Interferon-gamma | 2 | 2009 | 538 | 0.280 |
Why?
|
| Heart Diseases | 1 | 2012 | 522 | 0.270 |
Why?
|
| HIV | 1 | 2008 | 195 | 0.260 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2009 | 506 | 0.250 |
Why?
|
| Hepacivirus | 1 | 2008 | 273 | 0.250 |
Why?
|
| Peptides | 1 | 2009 | 861 | 0.240 |
Why?
|
| Hepatitis C | 1 | 2008 | 388 | 0.210 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2012 | 1159 | 0.210 |
Why?
|
| Isolated Noncompaction of the Ventricular Myocardium | 1 | 2023 | 44 | 0.200 |
Why?
|
| GTP-Binding Proteins | 1 | 2023 | 188 | 0.190 |
Why?
|
| Child | 8 | 2023 | 25739 | 0.180 |
Why?
|
| T-Lymphocytes | 2 | 2009 | 1814 | 0.180 |
Why?
|
| Bile Acids and Salts | 1 | 2023 | 259 | 0.170 |
Why?
|
| Adenosine A2 Receptor Agonists | 1 | 2018 | 15 | 0.150 |
Why?
|
| HIV Infections | 2 | 2008 | 2067 | 0.140 |
Why?
|
| Stroke Volume | 2 | 2023 | 530 | 0.140 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2018 | 57 | 0.140 |
Why?
|
| Purines | 1 | 2018 | 119 | 0.140 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2021 | 287 | 0.130 |
Why?
|
| Liver Cirrhosis | 1 | 2023 | 931 | 0.120 |
Why?
|
| Pyrazoles | 1 | 2018 | 328 | 0.120 |
Why?
|
| Curriculum | 1 | 2020 | 777 | 0.120 |
Why?
|
| Female | 7 | 2023 | 71659 | 0.110 |
Why?
|
| Young Adult | 4 | 2021 | 9887 | 0.110 |
Why?
|
| Coronary Artery Disease | 1 | 2021 | 883 | 0.110 |
Why?
|
| ROC Curve | 1 | 2015 | 615 | 0.110 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2023 | 3849 | 0.110 |
Why?
|
| Humans | 11 | 2023 | 133932 | 0.100 |
Why?
|
| Familial Primary Pulmonary Hypertension | 1 | 2012 | 22 | 0.100 |
Why?
|
| Boston | 1 | 2012 | 122 | 0.100 |
Why?
|
| Pulmonary Veno-Occlusive Disease | 1 | 2012 | 29 | 0.090 |
Why?
|
| Child, Preschool | 4 | 2018 | 14800 | 0.090 |
Why?
|
| Male | 6 | 2023 | 65882 | 0.090 |
Why?
|
| Adult | 5 | 2021 | 31946 | 0.090 |
Why?
|
| Infant | 3 | 2018 | 13161 | 0.090 |
Why?
|
| Internship and Residency | 1 | 2020 | 1250 | 0.080 |
Why?
|
| Cause of Death | 1 | 2012 | 502 | 0.080 |
Why?
|
| Retrospective Studies | 4 | 2018 | 17481 | 0.080 |
Why?
|
| Adolescent | 4 | 2018 | 20536 | 0.080 |
Why?
|
| Prospective Studies | 1 | 2020 | 6664 | 0.080 |
Why?
|
| Vaccines, Subunit | 1 | 2009 | 70 | 0.080 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2009 | 113 | 0.080 |
Why?
|
| Heart Defects, Congenital | 1 | 2020 | 1874 | 0.080 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2008 | 866 | 0.070 |
Why?
|
| Species Specificity | 1 | 2009 | 571 | 0.070 |
Why?
|
| Adoptive Transfer | 1 | 2009 | 241 | 0.070 |
Why?
|
| Mice, SCID | 1 | 2009 | 613 | 0.070 |
Why?
|
| Immunologic Memory | 1 | 2009 | 199 | 0.070 |
Why?
|
| Hypertension, Pulmonary | 1 | 2012 | 467 | 0.070 |
Why?
|
| Comorbidity | 1 | 2012 | 1615 | 0.070 |
Why?
|
| Hospital Mortality | 1 | 2012 | 1087 | 0.070 |
Why?
|
| Transposition of Great Vessels | 2 | 2018 | 133 | 0.070 |
Why?
|
| Mice, Inbred BALB C | 1 | 2009 | 1079 | 0.070 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 5505 | 0.060 |
Why?
|
| Aorta | 2 | 2021 | 561 | 0.060 |
Why?
|
| Age Factors | 1 | 2012 | 2977 | 0.060 |
Why?
|
| Interleukin-2 | 1 | 2005 | 250 | 0.060 |
Why?
|
| Immunization | 1 | 2005 | 315 | 0.060 |
Why?
|
| Vaccination | 1 | 2009 | 1011 | 0.050 |
Why?
|
| Infant, Newborn | 2 | 2018 | 8592 | 0.050 |
Why?
|
| Cytokines | 1 | 2009 | 1396 | 0.050 |
Why?
|
| Time Factors | 1 | 2012 | 6588 | 0.050 |
Why?
|
| Cell Line, Tumor | 1 | 2009 | 3751 | 0.050 |
Why?
|
| Dobutamine | 1 | 2021 | 59 | 0.040 |
Why?
|
| Middle Aged | 2 | 2012 | 29394 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 1 | 2009 | 4821 | 0.040 |
Why?
|
| Heart Failure | 1 | 2012 | 2417 | 0.040 |
Why?
|
| Heart Valves | 1 | 2018 | 54 | 0.040 |
Why?
|
| Risk Factors | 1 | 2012 | 11087 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2023 | 2295 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2018 | 353 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2012 | 13011 | 0.030 |
Why?
|
| Monitoring, Physiologic | 1 | 2018 | 389 | 0.030 |
Why?
|
| Heart Rate | 1 | 2018 | 600 | 0.030 |
Why?
|
| Pulmonary Artery | 1 | 2018 | 455 | 0.030 |
Why?
|
| Hemodynamics | 1 | 2018 | 868 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2018 | 1485 | 0.030 |
Why?
|
| Aged | 1 | 2012 | 21730 | 0.030 |
Why?
|
| Heart | 1 | 2018 | 749 | 0.030 |
Why?
|
| Mice | 1 | 2009 | 18911 | 0.020 |
Why?
|
| Animals | 1 | 2009 | 36398 | 0.020 |
Why?
|
| Hepatitis A Antigens | 1 | 2005 | 2 | 0.020 |
Why?
|
| HIV Core Protein p24 | 1 | 2005 | 12 | 0.020 |
Why?
|
| Tetanus Toxin | 1 | 2005 | 27 | 0.020 |
Why?
|
| Hepatitis A | 1 | 2005 | 32 | 0.020 |
Why?
|
| AIDS Vaccines | 1 | 2005 | 30 | 0.020 |
Why?
|
| Interleukin-4 | 1 | 2005 | 147 | 0.020 |
Why?
|
| Antibody Specificity | 1 | 2005 | 206 | 0.010 |
Why?
|
| Th2 Cells | 1 | 2005 | 191 | 0.010 |
Why?
|
| Antibody Formation | 1 | 2005 | 278 | 0.010 |
Why?
|
| Th1 Cells | 1 | 2005 | 159 | 0.010 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2005 | 269 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2005 | 358 | 0.010 |
Why?
|
| Hepatitis B | 1 | 2005 | 172 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 2005 | 550 | 0.010 |
Why?
|